Eukaryotic translation initiation factor 3 plays distinct roles at the mRNA entry and exit channels of the ribosomal preinitiation complex

  1. Colin Echeverría Aitken
  2. Petra Beznosková
  3. Vladislava Vlčkova
  4. Wen-Ling Chiu
  5. Fujun Zhou
  6. Leoš Shivaya Valášek  Is a corresponding author
  7. Alan G Hinnebusch  Is a corresponding author
  8. Jon R Lorsch  Is a corresponding author
  1. National Institutes of Health, United States
  2. Institute of Microbiology ASCR, Czech Republic
  3. PharmaEssentia Corporation, Taiwan

Abstract

Eukaryotic translation initiation factor 3 (eIF3) is a central player in recruitment of the pre-initiation complex (PIC) to mRNA. We probed the effects on mRNA recruitment of a library of S. cerevisiae eIF3 functional variants spanning its 5 essential subunits using an in vitro-reconstituted system. Mutations throughout eIF3 disrupt its interaction with the PIC and diminish its ability to accelerate recruitment to a native yeast mRNA. Alterations to the eIF3a CTD and eIF3b/i/g significantly slow mRNA recruitment, and mutations within eIF3b/i/g destabilize eIF2•GTP•Met-tRNAi binding to the PIC. Using model mRNAs lacking contacts with the 40S entry or exit channels, we uncover a critical role for eIF3 requiring the eIF3a NTD, in stabilizing mRNA interactions at the exit channel, and an ancillary role at the entry channel requiring residues of the eIF3a CTD. These functions are redundant: defects at each channel can be rescued by filling the other channel with mRNA.

Article and author information

Author details

  1. Colin Echeverría Aitken

    Laboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
  2. Petra Beznosková

    Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, Prague, Czech Republic
    Competing interests
    No competing interests declared.
  3. Vladislava Vlčkova

    Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, Prague, Czech Republic
    Competing interests
    No competing interests declared.
  4. Wen-Ling Chiu

    PharmaEssentia Corporation, Taipei, Taiwan
    Competing interests
    No competing interests declared.
  5. Fujun Zhou

    Laboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States
    Competing interests
    No competing interests declared.
  6. Leoš Shivaya Valášek

    Laboratory of Regulation of Gene Expression, Institute of Microbiology ASCR, Prague, Czech Republic
    For correspondence
    valasekl@biomed.cas.cz
    Competing interests
    No competing interests declared.
  7. Alan G Hinnebusch

    Laboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States
    For correspondence
    ahinnebusch@nih.gov
    Competing interests
    Alan G Hinnebusch, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1627-8395
  8. Jon R Lorsch

    Laboratory on the Mechanism and Regulation of Protein Synthesis, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States
    For correspondence
    jon.lorsch@nih.gov
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4521-4999

Funding

National Institutes of Health (Intramural Research Program)

  • Colin Echeverría Aitken
  • Wen-Ling Chiu
  • Fujun Zhou
  • Alan G Hinnebusch
  • Jon R Lorsch

Wellcome (090812/B/09/Z)

  • Colin Echeverría Aitken
  • Leoš Shivaya Valášek

Centrum of Excellence of the Czech Science Foundation (P305/12/G034)

  • Colin Echeverría Aitken
  • Leoš Shivaya Valášek

Leukemia and Lymphoma Society (5199-12)

  • Colin Echeverría Aitken

National Institutes of Health (GM62128)

  • Jon R Lorsch

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Nahum Sonenberg, McGill University, Canada

Version history

  1. Received: August 25, 2016
  2. Accepted: October 25, 2016
  3. Accepted Manuscript published: October 26, 2016 (version 1)
  4. Accepted Manuscript updated: October 31, 2016 (version 2)
  5. Version of Record published: December 12, 2016 (version 3)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 4,156
    views
  • 719
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Colin Echeverría Aitken
  2. Petra Beznosková
  3. Vladislava Vlčkova
  4. Wen-Ling Chiu
  5. Fujun Zhou
  6. Leoš Shivaya Valášek
  7. Alan G Hinnebusch
  8. Jon R Lorsch
(2016)
Eukaryotic translation initiation factor 3 plays distinct roles at the mRNA entry and exit channels of the ribosomal preinitiation complex
eLife 5:e20934.
https://doi.org/10.7554/eLife.20934

Share this article

https://doi.org/10.7554/eLife.20934

Further reading

    1. Biochemistry and Chemical Biology
    Valentina Kugler, Selina Schwaighofer ... Eduard Stefan
    Research Article

    Protein kinases act as central molecular switches in the control of cellular functions. Alterations in the regulation and function of protein kinases may provoke diseases including cancer. In this study we investigate the conformational states of such disease-associated kinases using the high sensitivity of the kinase conformation (KinCon) reporter system. We first track BRAF kinase activity conformational changes upon melanoma drug binding. Second, we also use the KinCon reporter technology to examine the impact of regulatory protein interactions on LKB1 kinase tumor suppressor functions. Third, we explore the conformational dynamics of RIP kinases in response to TNF pathway activation and small molecule interactions. Finally, we show that CDK4/6 interactions with regulatory proteins alter conformations which remain unaffected in the presence of clinically applied inhibitors. Apart from its predictive value, the KinCon technology helps to identify cellular factors that impact drug efficacies. The understanding of the structural dynamics of full-length protein kinases when interacting with small molecule inhibitors or regulatory proteins is crucial for designing more effective therapeutic strategies.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Sandeep K Ravala, Sendi Rafael Adame-Garcia ... John JG Tesmer
    Research Article

    PIP3-dependent Rac exchanger 1 (P-Rex1) is abundantly expressed in neutrophils and plays central roles in chemotaxis and cancer metastasis by serving as a guanine-nucleotide exchange factor (GEF) for Rac. The enzyme is synergistically activated by PIP3 and heterotrimeric Gβγ subunits, but mechanistic details remain poorly understood. While investigating the regulation of P-Rex1 by PIP3, we discovered that Ins(1,3,4,5)P4 (IP4) inhibits P-Rex1 activity and induces large decreases in backbone dynamics in diverse regions of the protein. Cryo-electron microscopy analysis of the P-Rex1·IP4 complex revealed a conformation wherein the pleckstrin homology (PH) domain occludes the active site of the Dbl homology (DH) domain. This configuration is stabilized by interactions between the first DEP domain (DEP1) and the DH domain and between the PH domain and a 4-helix bundle (4HB) subdomain that extends from the C-terminal domain of P-Rex1. Disruption of the DH–DEP1 interface in a DH/PH-DEP1 fragment enhanced activity and led to a more extended conformation in solution, whereas mutations that constrain the occluded conformation led to decreased GEF activity. Variants of full-length P-Rex1 in which the DH–DEP1 and PH–4HB interfaces were disturbed exhibited enhanced activity during chemokine-induced cell migration, confirming that the observed structure represents the autoinhibited state in living cells. Interactions with PIP3-containing liposomes led to disruption of these interfaces and increased dynamics protein-wide. Our results further suggest that inositol phosphates such as IP4 help to inhibit basal P-Rex1 activity in neutrophils, similar to their inhibitory effects on phosphatidylinositol-3-kinase.